Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Diplopia (DP) can have a significant negative impact on one's quality of life, many clinical investigations lend credence to the notion that acupuncture could be used to treat DP symptoms, randomized controlled trials are lacking, and only clinical observational studies have assessed the effectiveness of acupuncture in managing DP.

Purpose: To examine the influence of electro-acupuncture on diplopia in patients with oculomotor and abducens nerve palsy.

Methods: Forty eyes diagnosed with diplopia were randomly classified into study group (A) that received electro acupuncture therapy and standard prophylactic medications for 4 weeks at points selected for treating double vision, and control group (B) who received standard prophylactic medications only. The Hess screen test was used to measure degrees of deviation.

Results: There were statistically significant differences in the post-test (p = 0.38 and 0.003 respectively) in favor of the study group.

Discussion: In conclusion, integration between acupuncture therapies and standard prophylactic medications yields better results in treating DP.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pri.70074DOI Listing

Publication Analysis

Top Keywords

standard prophylactic
12
prophylactic medications
12
influence electro-acupuncture
8
electro-acupuncture diplopia
8
diplopia patients
8
patients oculomotor
8
oculomotor abducens
8
group received
8
diplopia
4
abducens nerves
4

Similar Publications

Background: Venous thromboembolism (VTE) is a preventable complication following orthopaedic surgery. While most guidelines focus on arthroplasty, a significant number of knee surgeries fall under non-arthroplasty procedures, where post-operative VTE prophylaxis recommendations vary depending on anaesthetic time and weight-bearing status. National guidelines and available literature suggest the use of VTE prophylaxis for these cases, yet adherence in clinical practice remains inconsistent.

View Article and Find Full Text PDF

Background Fasting during the month of Ramadan is practiced by over a billion Muslims worldwide. This religious observance, which involves complete abstention from food and fluids during daylight hours, may contribute to dehydration and increase the risk of venous thromboembolism (VTE), particularly in hot climates. Despite this theoretical concern, limited clinical evidence exists on the actual incidence and risk of VTE associated with prolonged fasting.

View Article and Find Full Text PDF

Introduction: In the majority of patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (HAE-C1INH), effective long-term prophylactic (LTP) treatment can achieve complete disease control. Lanadelumab is one of the first-line option recommended for this purpose. Our study aimed to evaluate changes in disease control, quality of life, and attack frequency among Romanian HAE-C1INH patients, during the first year of treatment with lanadelumab.

View Article and Find Full Text PDF

Background/aims: Ampullary adenomas are precancerous lesions requiring accurate diagnosis and timely intervention to prevent malignant transformation. Endoscopic papillectomy (EP) has emerged as a less invasive alternative to surgery; however, technical variations in practice remain. This study evaluated contemporary real-world approaches to the diagnosis, treatment, and surveillance of ampullary adenomas among pancreatobiliary endoscopists.

View Article and Find Full Text PDF

Factor VIII Pharmacokinetics in Mexican Patients With Hemophilia A.

Arch Med Res

September 2025

Unidad de Investigación Médica en Trombosis, Hemostasia y Aterogénesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Electronic address:

Introduction: Treatment of patients with severe hemophilia A requires the replacement of deficient factor VIII. To reach the international standards of care, an optimal dose of factor VIII should be administered based on pharmacokinetic analysis. However, in Mexico factor VIII pharmacokinetics is not used.

View Article and Find Full Text PDF